Tag: Emblem
Boston’s Empower leadless pacemaker demonstrates “excellent overall clinical performance” in MODULAR...
Boston Scientific recently announced late-breaking data from the MODULAR ATP clinical trial investigating the pacing performance of the company’s Empower leadless pacemaker. The data...
US FDA approves Boston Scientific Emblem MRI S-ICD system
Boston Scientific has received US Food and Drug Administration (FDA) approval for the Emblem MRI subcutaneous implantable defibrillator (S-ICD) system, as well as magnetic...
Boston Scientific receives CE mark for MRI labelling of Emblem S-ICD...
Boston Scientific has received CE mark approval for the new Emblem MRI subcutaneous implantable defibrillator (S-ICD) system, as well as magnetic resonance (MR) conditional labelling for all previously implanted Emblem S-ICD systems.
Boston Scientific initiates study to assess Emblem S-ICD in primary prevention...
The UNTOUCHED study will compare outcomes during an 18-month follow-up period to objective performance criteria derived from the MADIT-RIT study, which evaluated shock rates in 1,500 patients implanted with transvenous ICD devices.
Entirely Subcutaneous ICD (S-ICD) poised to revolutionise treatment of Sudden Cardiac...
The publication of important new long-term data from nearly 900 patients and a rapid evolution in the technology is putting entirely the Subcutaneous Implantable...